Epstein Secrets

From: Boris Nikolic < To: "Jeffrey Epstein [email protected] <jeevacationggmail.com> Subject: FW: Foundation Medicine Extends and Expands Collaboration to Provide

From: Boris Nikolic < To: "Jeffrey Epstein [email protected] <j

From: Boris Nikolic < To: "Jeffrey Epstein acevacation@gmail

cology Programs CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine today announced it has extended and expanded its ongoing collaboration with Novartis to provide molecular information and comprehensive genomic profiling analysis in support of many of Novartis' clinical oncology programs. The colla

startup. Cambridge-based Editas Medicine is announcing a $120 million Series B round led by Bill Gates's chief advisor for science and technology, Boris Nikolic. The list of financiers teaming with Nikolic reads like a rolodex of so-called crossover investors, who invest in both public and private entities,

ncing a $120 million Series B round led by Bill Gates's chief advisor for science and technology, Boris Nikolic. The list of financiers teaming with Nikolic reads like a rolodex of so-called crossover investors, who invest in both public and private entities, and corporate venture arms. Among them: Deer

ates's chief advisor for science and technology, Boris Nikolic. The list of financiers teaming with Niko

h formed after Editas, and both have made strides as well: Intellia raised a $15 million Series A last year and then cut a broad collaboration with Novartis in January. CRISPR hauled in $64 million in April in a round that was led by EFTA00635886 Celgene (NASDAQ: CELG) and the venture arm of GlaxoSmith

1990 and 1992 and subsequently joined the World Bank where he was involved in the development of the financial sector in Russia. Boris Nlkolk Dr. Boris Nikolic is a Chief Advisor for Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gat

Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gates Foundation (BMGF). Boris has led investment activities at these Gates-affiliated organizations on both the for-profit and non-for-profit aspects of Bill Gates' activities.

ceived his MD from Zagreb Medical School and his clinical training from the University's Medical Center, University of Zagreb, Croatia. In 1994, Dr. Nikolic joined the Harvard Graduate Program in Immunology. Subsequently, Boris continued to serve in roles of increasing authority including postdoctoral f

s, improving their effectiveness but shrinking their addressable markets. Drug companies will need to adapt their marketing strategies accordingly. Novartis CEO Joe Jimenez called out the explosion in DNA sequencing as a driver for R&D productivity "allowing new areas of discovery that have never been po